Active Daily Care Eat Smart Health Hacks Recommended
About Contact The Library

Can Cancer Cause Diarrhoea? | Unpacking the Link

Yes, cancer itself and its treatments can frequently lead to diarrhoea through various direct and indirect mechanisms affecting the digestive system.

When someone experiences persistent changes in their bowel habits, particularly diarrhoea, it naturally raises questions and concerns. It’s a symptom that can disrupt daily life and signal underlying health issues, including those related to cancer. Understanding the connections between cancer and diarrhoea can help clarify these concerns.

Direct Tumor Effects on the Digestive System

Certain cancers can directly impact the digestive tract, leading to diarrhoea. The location and type of tumor play a significant role in how symptoms manifest.

For instance, tumors located in the colon or rectum can physically obstruct the bowel, leading to alternating constipation and diarrhoea, or a constant feeling of incomplete emptying. These tumors might also irritate the bowel lining, causing increased mucus production and more frequent, looser stools.

Cancers of the pancreas, especially those affecting its exocrine function, can impair the production of digestive enzymes. This insufficiency means food isn’t properly broken down and absorbed, leading to malabsorption diarrhoea characterized by fatty, foul-smelling stools (steatorrhea). Neuroendocrine tumors, which can arise in various parts of the body, sometimes produce hormones that directly stimulate bowel motility and fluid secretion, resulting in severe, watery diarrhoea.

Cancer Treatments and Their Gastrointestinal Side Effects

Many effective cancer treatments, while targeting cancer cells, can also affect healthy cells, particularly those that divide rapidly, such as the lining of the digestive tract. This collateral effect is a common reason for diarrhoea.

Chemotherapy-Induced Diarrhoea (CID)

Chemotherapy drugs work by attacking fast-growing cells, which unfortunately includes the cells lining the intestines. Damage to these cells, known as mucositis, disrupts the gut’s ability to absorb water and nutrients, leading to inflammation and increased fluid secretion. The severity of CID can vary widely depending on the specific chemotherapy agent, its dose, and the individual’s overall health. It typically begins a few days after treatment and resolves once the gut lining has a chance to repair.

Certain chemotherapy drugs, such as fluorouracil (5-FU), capecitabine, irinotecan, and methotrexate, are particularly known for causing diarrhoea. Managing CID often involves dietary adjustments, anti-diarrheal medications, and in severe cases, temporary interruptions of treatment or dose reductions.

Radiation Therapy to the Abdomen and Pelvis

Radiation therapy directed at the abdominal or pelvic regions, common for cancers of the rectum, prostate, cervix, or bladder, can cause inflammation and damage to the small and large intestines. This condition is known as radiation enteritis. Acute radiation enteritis occurs during or shortly after treatment, as the radiation directly irritates the bowel lining, leading to increased frequency of bowel movements, urgency, and watery stools.

Chronic radiation enteritis can develop months or even years after treatment, resulting from permanent changes to the bowel tissue, such as scarring, narrowing, or impaired blood supply. This can cause ongoing malabsorption and persistent diarrhoea. Management strategies include dietary changes, anti-diarrheal agents, and sometimes more specialized interventions for chronic cases.

Immunotherapy and Targeted Therapies

Newer cancer treatments, including immunotherapies and targeted therapies, can also induce diarrhoea through distinct mechanisms.

Immunotherapies, such as checkpoint inhibitors, work by unleashing the body’s immune system to fight cancer. However, this heightened immune activity can sometimes mistakenly attack healthy tissues, including the gastrointestinal tract. This can lead to immune-related adverse events (irAEs) like colitis, an inflammation of the colon, which manifests as diarrhoea, abdominal pain, and sometimes blood in the stool. The onset of irAEs can be delayed, appearing weeks or months after treatment initiation.

Targeted therapies are designed to interfere with specific molecules involved in cancer cell growth and survival. While often more precise than traditional chemotherapy, they can still have side effects. For example, certain tyrosine kinase inhibitors (TKIs) can disrupt signaling pathways in healthy gut cells, leading to increased fluid secretion and motility, resulting in diarrhoea. The management of diarrhoea from these therapies often involves specific anti-diarrheal medications and careful monitoring.

Paraneoplastic Syndromes and Diarrhoea

Paraneoplastic syndromes are rare conditions caused by substances released by cancer cells or by the body’s immune response to the cancer, rather than by the tumor itself directly invading an organ. These syndromes can affect various body systems, including the digestive tract.

Some tumors, particularly certain neuroendocrine tumors like VIPomas (which produce vasoactive intestinal peptide) or medullary thyroid carcinoma (which produces calcitonin), can secrete hormones or other bioactive substances into the bloodstream. These substances can then travel to the intestines and stimulate excessive fluid secretion and rapid bowel movements, leading to severe, watery diarrhoea. This type of diarrhoea can be particularly challenging to manage due to its hormonal origin.

Here is a summary of common cancer types and their potential to cause diarrhoea:

Cancer Type Primary Mechanism for Diarrhoea Treatment-Related Diarrhoea
Colorectal Cancer Direct obstruction, irritation, inflammation Chemotherapy, radiation, surgery
Pancreatic Cancer Enzyme insufficiency, direct tumor effects Chemotherapy, surgery
Neuroendocrine Tumors Hormone secretion (e.g., VIP, serotonin) Chemotherapy, targeted therapy
Lymphoma Direct bowel involvement, systemic effects Chemotherapy, radiation, immunotherapy
Gastric Cancer Malabsorption post-surgery, systemic effects Chemotherapy, surgery

Infections and Malabsorption in Cancer Patients

Cancer patients are often more susceptible to infections and can experience malabsorption due to the disease or its treatments, both of which can cause diarrhoea.

Increased Susceptibility to Infections

Many cancer treatments, especially chemotherapy, suppress the immune system, leaving patients vulnerable to infections. Gastrointestinal infections, caused by bacteria (like Clostridioides difficile, Salmonella), viruses (like norovirus), or parasites, can lead to significant diarrhoea. C. difficile infection is particularly concerning in cancer patients, often arising after antibiotic use, and can cause severe, watery diarrhoea and colitis. CDC provides extensive information on infection prevention.

Malabsorption Syndromes

Cancer or its treatments can impair the body’s ability to absorb nutrients. Surgical removal of parts of the small intestine (common in gastrointestinal cancers) can lead to short bowel syndrome, where there isn’t enough surface area to absorb nutrients, resulting in malabsorption diarrhoea. Radiation to the small bowel can also cause long-term damage to the absorptive cells. Pancreatic cancer or pancreatic surgery can cause exocrine pancreatic insufficiency, where digestive enzymes are lacking, leading to fatty stools and nutrient deficiencies. These conditions require careful dietary management and often enzyme replacement.

Surgical Interventions and Post-Operative Changes

Surgery for gastrointestinal cancers can dramatically alter digestive function and is a frequent cause of diarrhoea.

Resection of parts of the bowel, particularly the colon or small intestine, can change transit time, reduce water absorption, and alter the gut microbiome. For example, removal of the ileocecal valve (the junction between the small and large intestines) can lead to rapid passage of contents into the colon, causing diarrhoea. Procedures like total gastrectomy (removal of the stomach) can lead to “dumping syndrome,” where food moves too quickly into the small intestine, causing rapid fluid shifts and diarrhoea shortly after eating.

Bile acid malabsorption can occur after surgery involving the ileum, as this is where bile acids are normally reabsorbed. When bile acids reach the colon in excess, they stimulate water secretion, leading to chronic watery diarrhoea. Surgical creation of an ostomy (e.g., ileostomy or colostomy) also changes the way waste is eliminated, often resulting in looser or more frequent output, which can be perceived as diarrhoea.

Here is a comparison of different treatment types and their diarrhoea-causing potential:

Treatment Type Mechanism of Diarrhoea Typical Onset
Chemotherapy Mucositis, damage to gut lining cells Days to weeks post-treatment
Radiation Therapy Inflammation of intestinal lining (enteritis) During or months/years post-treatment
Immunotherapy Immune-related colitis/enteritis Weeks to months post-treatment
Targeted Therapy Disruption of cellular signaling in gut Days to weeks post-treatment
Surgery Altered anatomy, malabsorption, rapid transit Immediately post-op, or long-term

Medications Beyond Cancer Treatment

Beyond specific cancer therapies, other medications often prescribed to cancer patients can also contribute to diarrhoea. Antibiotics, frequently used to prevent or treat infections in immunocompromised patients, can disrupt the natural balance of gut bacteria, leading to antibiotic-associated diarrhoea. Pain medications, especially opioids, can cause constipation, but sometimes, when discontinued, they can lead to rebound diarrhoea. Even some antacids or supplements can have a laxative effect. It’s helpful to consider all medications a patient is taking when evaluating the cause of diarrhoea. National Cancer Institute offers detailed information on cancer treatment side effects.

When to Seek Medical Guidance

Diarrhoea in a cancer patient is never a symptom to ignore. It can lead to dehydration, electrolyte imbalances, and significant weight loss, all of which can severely impact a patient’s strength and ability to continue treatment. Patients experiencing new or worsening diarrhoea should always communicate this promptly with their healthcare team. This includes changes in frequency, consistency, the presence of blood or mucus, or accompanying symptoms like fever, chills, or severe abdominal pain. Early intervention can often prevent more serious complications and improve comfort.

References & Sources

  • Centers for Disease Control and Prevention. “cdc.gov” Provides information on various infections, including those affecting the gastrointestinal tract.
  • National Cancer Institute. “cancer.gov” Offers comprehensive details on cancer types, treatments, and their associated side effects.
Mo Maruf
Founder & Lead Editor

Mo Maruf

I created WellFizz to bridge the gap between vague wellness advice and actionable solutions. My mission is simple: to decode the research and give you practical tools you can actually use.

Beyond the data, I am a passionate traveler. I believe that stepping away from the screen to explore new environments is essential for mental clarity and physical vitality.

Please use a real email you check. If it's fake or mistyped, your message won't reach us and we can't reply — wrong addresses are rejected automatically.